nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—liver cancer—sclerosing cholangitis	0.508	1	CtDrD
Doxorubicin—NOS2—sclerosing cholangitis	0.372	1	CbGaD
Doxorubicin—ABCB11—bile canaliculus—sclerosing cholangitis	0.0195	0.297	CbGeAlD
Doxorubicin—ABCC2—bile canaliculus—sclerosing cholangitis	0.00991	0.151	CbGeAlD
Doxorubicin—ABCB8—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00741	0.135	CbGpPWpGaD
Doxorubicin—ABCB11—bile duct—sclerosing cholangitis	0.00609	0.0928	CbGeAlD
Doxorubicin—ABCB11—bile—sclerosing cholangitis	0.00468	0.0713	CbGeAlD
Doxorubicin—ABCC3—bile duct—sclerosing cholangitis	0.00387	0.0591	CbGeAlD
Doxorubicin—ABCC6—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00347	0.0631	CbGpPWpGaD
Doxorubicin—ABCC2—bile duct—sclerosing cholangitis	0.0031	0.0472	CbGeAlD
Doxorubicin—ABCC10—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00303	0.0551	CbGpPWpGaD
Doxorubicin—ABCC2—bile—sclerosing cholangitis	0.00238	0.0363	CbGeAlD
Doxorubicin—NOS1—Effects of Nitric Oxide—NOS2—sclerosing cholangitis	0.00178	0.0324	CbGpPWpGaD
Doxorubicin—ABCB11—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00163	0.0297	CbGpPWpGaD
Doxorubicin—YWHAG—Activation of BH3-only proteins—BCL2L11—sclerosing cholangitis	0.00136	0.0248	CbGpPWpGaD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.00135	0.0246	CbGpPWpGaD
Doxorubicin—YWHAG—FoxO family signaling—MST1—sclerosing cholangitis	0.00126	0.023	CbGpPWpGaD
Doxorubicin—CBR3—NRF2 pathway—GGT1—sclerosing cholangitis	0.00123	0.0224	CbGpPWpGaD
Doxorubicin—ABCC3—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00117	0.0214	CbGpPWpGaD
Doxorubicin—XDH—Effects of Nitric Oxide—NOS2—sclerosing cholangitis	0.00115	0.0209	CbGpPWpGaD
Doxorubicin—NDUFS2—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00114	0.0208	CbGpPWpGaD
Doxorubicin—NOS3—Effects of Nitric Oxide—NOS2—sclerosing cholangitis	0.00104	0.019	CbGpPWpGaD
Doxorubicin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00102	0.0186	CbGpPWpGaD
Doxorubicin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000982	0.0179	CbGpPWpGaD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—BCL2L11—sclerosing cholangitis	0.000976	0.0178	CbGpPWpGaD
Doxorubicin—AKR1A1—pancreas—sclerosing cholangitis	0.000969	0.0148	CbGeAlD
Doxorubicin—ABCC2—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.000931	0.0169	CbGpPWpGaD
Doxorubicin—NQO1—gall bladder—sclerosing cholangitis	0.000921	0.014	CbGeAlD
Doxorubicin—ABCC1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00092	0.0167	CbGpPWpGaD
Doxorubicin—ABCB8—liver—sclerosing cholangitis	0.000829	0.0126	CbGeAlD
Doxorubicin—ABCC3—gall bladder—sclerosing cholangitis	0.000826	0.0126	CbGeAlD
Doxorubicin—CBR1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000799	0.0145	CbGpPWpGaD
Doxorubicin—YWHAG—FoxO family signaling—BCL2L11—sclerosing cholangitis	0.000796	0.0145	CbGpPWpGaD
Doxorubicin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000779	0.0142	CbGpPWpGaD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000774	0.0141	CbGpPWpGaD
Doxorubicin—NOS1—Nitric oxide stimulates guanylate cyclase—NOS2—sclerosing cholangitis	0.00074	0.0135	CbGpPWpGaD
Doxorubicin—NDUFS2—pancreas—sclerosing cholangitis	0.000729	0.0111	CbGeAlD
Doxorubicin—NDUFS3—pancreas—sclerosing cholangitis	0.000721	0.011	CbGeAlD
Doxorubicin—DHCR7—pancreas—sclerosing cholangitis	0.000685	0.0104	CbGeAlD
Doxorubicin—YWHAG—pancreas—sclerosing cholangitis	0.000628	0.00957	CbGeAlD
Doxorubicin—AKR1A1—liver—sclerosing cholangitis	0.000616	0.00939	CbGeAlD
Doxorubicin—RALBP1—pancreas—sclerosing cholangitis	0.000567	0.00865	CbGeAlD
Doxorubicin—NOS2—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.000566	0.0103	CbGpPWpGaD
Doxorubicin—NDUFS7—liver—sclerosing cholangitis	0.00056	0.00854	CbGeAlD
Doxorubicin—NOS1—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—sclerosing cholangitis	0.00056	0.0102	CbGpPWpGaD
Doxorubicin—AKR1C3—pancreas—sclerosing cholangitis	0.000523	0.00797	CbGeAlD
Doxorubicin—AURKA—liver—sclerosing cholangitis	0.000521	0.00794	CbGeAlD
Doxorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—sclerosing cholangitis	0.000517	0.0094	CbGpPWpGaD
Doxorubicin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000496	0.00903	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000478	0.0087	CbGpPWpGaD
Doxorubicin—NOS3—Angiogenesis—HIF1A—sclerosing cholangitis	0.000476	0.00866	CbGpPWpGaD
Doxorubicin—NDUFS2—liver—sclerosing cholangitis	0.000464	0.00707	CbGeAlD
Doxorubicin—ABCC1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—sclerosing cholangitis	0.000464	0.00844	CbGpPWpGaD
Doxorubicin—NDUFS3—liver—sclerosing cholangitis	0.000458	0.00699	CbGeAlD
Doxorubicin—AKR1C3—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00045	0.00819	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00044	0.008	CbGpPWpGaD
Doxorubicin—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.000438	0.00796	CbGpPWpGaD
Doxorubicin—DHCR7—liver—sclerosing cholangitis	0.000436	0.00664	CbGeAlD
Doxorubicin—NOS3—Nitric oxide stimulates guanylate cyclase—NOS2—sclerosing cholangitis	0.000433	0.00788	CbGpPWpGaD
Doxorubicin—ABCC6—liver—sclerosing cholangitis	0.000424	0.00647	CbGeAlD
Doxorubicin—NQO1—pancreas—sclerosing cholangitis	0.000424	0.00647	CbGeAlD
Doxorubicin—NOS3—VEGFR1 specific signals—HIF1A—sclerosing cholangitis	0.000409	0.00745	CbGpPWpGaD
Doxorubicin—YWHAG—liver—sclerosing cholangitis	0.0004	0.00609	CbGeAlD
Doxorubicin—XDH—liver—sclerosing cholangitis	0.00039	0.00594	CbGeAlD
Doxorubicin—ABCB11—liver—sclerosing cholangitis	0.000381	0.0058	CbGeAlD
Doxorubicin—NOS3—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.000367	0.00668	CbGpPWpGaD
Doxorubicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000366	0.00666	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000362	0.00659	CbGpPWpGaD
Doxorubicin—RALBP1—liver—sclerosing cholangitis	0.000361	0.0055	CbGeAlD
Doxorubicin—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.000359	0.00654	CbGpPWpGaD
Doxorubicin—NOS3—liver—sclerosing cholangitis	0.000355	0.00541	CbGeAlD
Doxorubicin—CBR1—NRF2 pathway—GGT1—sclerosing cholangitis	0.000339	0.00617	CbGpPWpGaD
Doxorubicin—CBR1—liver—sclerosing cholangitis	0.000337	0.00514	CbGeAlD
Doxorubicin—AKR1C3—liver—sclerosing cholangitis	0.000333	0.00507	CbGeAlD
Doxorubicin—NOS3—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—sclerosing cholangitis	0.000328	0.00596	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.000325	0.00592	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—BCL2L11—sclerosing cholangitis	0.000317	0.00576	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000317	0.00576	CbGpPWpGaD
Doxorubicin—POR—liver—sclerosing cholangitis	0.000304	0.00463	CbGeAlD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000299	0.00544	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.000297	0.00541	CbGpPWpGaD
Doxorubicin—NOS1—Platelet homeostasis—NOS2—sclerosing cholangitis	0.000288	0.00524	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000279	0.00507	CbGpPWpGaD
Doxorubicin—NOS2—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.000273	0.00497	CbGpPWpGaD
Doxorubicin—NOS2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000273	0.00497	CbGpPWpGaD
Doxorubicin—NQO1—liver—sclerosing cholangitis	0.00027	0.00411	CbGeAlD
Doxorubicin—XDH—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.000266	0.00485	CbGpPWpGaD
Doxorubicin—ABCC3—liver—sclerosing cholangitis	0.000242	0.00369	CbGeAlD
Doxorubicin—ABCC10—liver—sclerosing cholangitis	0.000241	0.00368	CbGeAlD
Doxorubicin—ABCC1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000232	0.00422	CbGpPWpGaD
Doxorubicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.000226	0.0041	CbGpPWpGaD
Doxorubicin—CYP1B1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000224	0.00408	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.000212	0.00386	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.000207	0.00376	CbGpPWpGaD
Doxorubicin—NQO1—NRF2 pathway—GGT1—sclerosing cholangitis	0.000198	0.0036	CbGpPWpGaD
Doxorubicin—ABCC2—liver—sclerosing cholangitis	0.000194	0.00295	CbGeAlD
Doxorubicin—NOS3—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.000193	0.00351	CbGpPWpGaD
Doxorubicin—CYP1B1—liver—sclerosing cholangitis	0.00019	0.00289	CbGeAlD
Doxorubicin—NQO1—Amino acid and derivative metabolism—GOT2—sclerosing cholangitis	0.000187	0.00341	CbGpPWpGaD
Doxorubicin—ABCC1—liver—sclerosing cholangitis	0.000171	0.0026	CbGeAlD
Doxorubicin—NOS3—Platelet homeostasis—NOS2—sclerosing cholangitis	0.000169	0.00307	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—ABCB4—sclerosing cholangitis	0.000166	0.00303	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—ABCB4—sclerosing cholangitis	0.000166	0.00303	CbGpPWpGaD
Doxorubicin—NQO1—Amino acid and derivative metabolism—GOT1—sclerosing cholangitis	0.000162	0.00294	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000157	0.00286	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—ABCB4—sclerosing cholangitis	0.000156	0.00285	CbGpPWpGaD
Doxorubicin—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.000147	0.00268	CbGpPWpGaD
Doxorubicin—ABCG2—liver—sclerosing cholangitis	0.000141	0.00215	CbGeAlD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.000134	0.00244	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—ABCB4—sclerosing cholangitis	0.000133	0.00242	CbGpPWpGaD
Doxorubicin—CYP2B6—liver—sclerosing cholangitis	0.00013	0.00199	CbGeAlD
Doxorubicin—ABCC3—NRF2 pathway—GGT1—sclerosing cholangitis	0.000126	0.00228	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ABCB4—sclerosing cholangitis	0.000124	0.00226	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000123	0.00223	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000123	0.00223	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000114	0.00208	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000114	0.00207	CbGpPWpGaD
Doxorubicin—ABCB1—pancreas—sclerosing cholangitis	0.000109	0.00167	CbGeAlD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000108	0.00196	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000103	0.00188	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000103	0.00188	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—GGT1—sclerosing cholangitis	9.95e-05	0.00181	CbGpPWpGaD
Doxorubicin—CYP3A4—liver—sclerosing cholangitis	9.84e-05	0.0015	CbGeAlD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	9.79e-05	0.00178	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	9.72e-05	0.00177	CbGpPWpGaD
Doxorubicin—CYP2D6—liver—sclerosing cholangitis	9.68e-05	0.00148	CbGeAlD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	9.61e-05	0.00175	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	8.46e-05	0.00154	CbGpPWpGaD
Doxorubicin—CYP1B1—Biological oxidations—GGT1—sclerosing cholangitis	8.35e-05	0.00152	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	8.08e-05	0.00147	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—GOT2—sclerosing cholangitis	7.91e-05	0.00144	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—GOT2—sclerosing cholangitis	7.91e-05	0.00144	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	7.82e-05	0.00142	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—GOT2—sclerosing cholangitis	7.43e-05	0.00135	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ABCB4—sclerosing cholangitis	7.24e-05	0.00132	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—BCL2L11—sclerosing cholangitis	7.07e-05	0.00129	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ABCB4—sclerosing cholangitis	6.99e-05	0.00127	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—NOS2—sclerosing cholangitis	6.97e-05	0.00127	CbGpPWpGaD
Doxorubicin—ABCB1—liver—sclerosing cholangitis	6.96e-05	0.00106	CbGeAlD
Doxorubicin—NDUFS7—Metabolism—GOT1—sclerosing cholangitis	6.83e-05	0.00124	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—GGT1—sclerosing cholangitis	6.83e-05	0.00124	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—GGT1—sclerosing cholangitis	6.83e-05	0.00124	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—GOT1—sclerosing cholangitis	6.83e-05	0.00124	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ABCB4—sclerosing cholangitis	6.5e-05	0.00118	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—NOS2—sclerosing cholangitis	6.45e-05	0.00117	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	6.44e-05	0.00117	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—GOT1—sclerosing cholangitis	6.42e-05	0.00117	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—GGT1—sclerosing cholangitis	6.42e-05	0.00117	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—GOT2—sclerosing cholangitis	6.32e-05	0.00115	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	6.15e-05	0.00112	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ABCB4—sclerosing cholangitis	5.91e-05	0.00107	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—GOT2—sclerosing cholangitis	5.9e-05	0.00107	CbGpPWpGaD
Doxorubicin—NOS1—Disease—GOT2—sclerosing cholangitis	5.72e-05	0.00104	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	5.59e-05	0.00102	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—GGT1—sclerosing cholangitis	5.57e-05	0.00101	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—GGT1—sclerosing cholangitis	5.46e-05	0.000993	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—GOT1—sclerosing cholangitis	5.46e-05	0.000993	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—GGT1—sclerosing cholangitis	5.09e-05	0.000926	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—GOT1—sclerosing cholangitis	5.09e-05	0.000926	CbGpPWpGaD
Doxorubicin—NOS1—Disease—GOT1—sclerosing cholangitis	4.94e-05	0.000898	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ABCB4—sclerosing cholangitis	4.79e-05	0.000871	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ABCB4—sclerosing cholangitis	4.59e-05	0.000836	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	4.57e-05	0.000832	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	4.41e-05	0.000802	CbGpPWpGaD
Doxorubicin—NOS2—Disease—GOT2—sclerosing cholangitis	4.31e-05	0.000785	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	4.23e-05	0.000769	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—GOT2—sclerosing cholangitis	3.96e-05	0.000721	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—BCL2L11—sclerosing cholangitis	3.92e-05	0.000713	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	3.87e-05	0.000704	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—NOS2—sclerosing cholangitis	3.78e-05	0.000688	CbGpPWpGaD
Doxorubicin—NOS2—Disease—GOT1—sclerosing cholangitis	3.72e-05	0.000678	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ABCB4—sclerosing cholangitis	3.6e-05	0.000655	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ABCB4—sclerosing cholangitis	3.48e-05	0.000633	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GOT2—sclerosing cholangitis	3.44e-05	0.000626	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HIF1A—sclerosing cholangitis	3.44e-05	0.000625	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—GOT1—sclerosing cholangitis	3.42e-05	0.000623	CbGpPWpGaD
Doxorubicin—NOS3—Disease—GOT2—sclerosing cholangitis	3.35e-05	0.000609	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GOT2—sclerosing cholangitis	3.32e-05	0.000604	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	3.31e-05	0.000603	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—BCL2L11—sclerosing cholangitis	3.31e-05	0.000603	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	3.2e-05	0.000583	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	3.17e-05	0.000576	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NOS2—sclerosing cholangitis	3.12e-05	0.000568	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GOT2—sclerosing cholangitis	3.09e-05	0.000562	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HIF1A—sclerosing cholangitis	3.01e-05	0.000547	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GGT1—sclerosing cholangitis	2.97e-05	0.00054	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GOT1—sclerosing cholangitis	2.97e-05	0.00054	CbGpPWpGaD
Doxorubicin—NOS3—Disease—GOT1—sclerosing cholangitis	2.89e-05	0.000526	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GOT1—sclerosing cholangitis	2.87e-05	0.000521	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GGT1—sclerosing cholangitis	2.87e-05	0.000521	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GOT2—sclerosing cholangitis	2.81e-05	0.00051	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GGT1—sclerosing cholangitis	2.66e-05	0.000485	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GOT1—sclerosing cholangitis	2.66e-05	0.000485	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HIF1A—sclerosing cholangitis	2.59e-05	0.000471	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	2.53e-05	0.00046	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GOT1—sclerosing cholangitis	2.42e-05	0.000441	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GGT1—sclerosing cholangitis	2.42e-05	0.000441	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HIF1A—sclerosing cholangitis	2.38e-05	0.000433	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB4—sclerosing cholangitis	2.32e-05	0.000422	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GOT2—sclerosing cholangitis	2.28e-05	0.000414	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GOT2—sclerosing cholangitis	2.18e-05	0.000397	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOS2—sclerosing cholangitis	2.17e-05	0.000394	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—GOT2—sclerosing cholangitis	2.04e-05	0.000371	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HIF1A—sclerosing cholangitis	2.01e-05	0.000366	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GOT1—sclerosing cholangitis	1.96e-05	0.000357	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GGT1—sclerosing cholangitis	1.96e-05	0.000357	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GGT1—sclerosing cholangitis	1.88e-05	0.000343	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GOT1—sclerosing cholangitis	1.88e-05	0.000343	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NOS2—sclerosing cholangitis	1.83e-05	0.000333	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—GOT1—sclerosing cholangitis	1.76e-05	0.000321	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	1.71e-05	0.000311	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GOT2—sclerosing cholangitis	1.71e-05	0.000311	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HIF1A—sclerosing cholangitis	1.67e-05	0.000303	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GOT2—sclerosing cholangitis	1.65e-05	0.000301	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	1.61e-05	0.000293	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GOT2—sclerosing cholangitis	1.5e-05	0.000274	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GGT1—sclerosing cholangitis	1.48e-05	0.000268	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GOT1—sclerosing cholangitis	1.48e-05	0.000268	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GOT1—sclerosing cholangitis	1.43e-05	0.00026	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GGT1—sclerosing cholangitis	1.43e-05	0.00026	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HIF1A—sclerosing cholangitis	1.41e-05	0.000256	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GOT1—sclerosing cholangitis	1.3e-05	0.000236	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GGT1—sclerosing cholangitis	1.3e-05	0.000236	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HIF1A—sclerosing cholangitis	1.23e-05	0.000223	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS2—sclerosing cholangitis	1.12e-05	0.000203	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GOT2—sclerosing cholangitis	1.1e-05	0.000201	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	1.05e-05	0.000192	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GOT1—sclerosing cholangitis	9.52e-06	0.000173	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GGT1—sclerosing cholangitis	9.52e-06	0.000173	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GOT2—sclerosing cholangitis	8.13e-06	0.000148	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	7.66e-06	0.000139	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GGT1—sclerosing cholangitis	7.02e-06	0.000128	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GOT1—sclerosing cholangitis	7.02e-06	0.000128	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	6.62e-06	0.00012	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	6.62e-06	0.00012	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	5.01e-06	9.12e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	4.33e-06	7.87e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	4.33e-06	7.87e-05	CbGpPWpGaD
